|
|
|
|
|
|
|
|
|
|
|
Changing the Digital Health Playing Field
Otsuka's Christopher Koenen discusses moving beyond the pill to extend the value being delivered to patients
|
|
Pharma and Biotech's 2020 Full-Year View
Peter Young examines the key biopharma stock numbers and industry trends from a year that challenged the conduct of business and market stability like never before
|
|
The Amazon Effect: A Data-Fueled Customer Experience
What the future emergence of Amazon Pharmacy and the company's aim to own the health experience may mean for pharma manufacturers’ engagement strategies and role in Rx delivery
|
|
ADVERTISEMENT
Pharmaceutical Executive®
Tuesday, May 11, 2021 at 11am EDT | 10am CDT | 8am PDT
Read more
|
|
ADVERTISEMENT
How to Build Productive, Strategic Sponsor-CRO Partnerships
Tuesday, April 27, 2021 at 1pm EDT | 12pm CDT | 10am PDT
Read more
|
|
|
April 20-22:
Global Pharmaceutical Regulatory Affairs Summit
Virtual Event
April 28-29:
31st Annual European Pharma Congress
Virtual Event
June 15-17:
Patient Support Services
Virtual Event
|
|
|
|
|
|
The Digital Denouement of COVID
Mike Starich, CEO of Orion Talent, and Dr. Armand Balboni, CEO of Appili Therapeutics, discuss how veterans have specific skills and qualities that can set them up for success in pharma, and what the industry can do to uncover their potential
|
|
|
|
ADVERTISEMENT
Pharmaceutical Executive®
Tuesday, May 11, 2021 at 11am EDT | 10am CDT | 8am PDT
Read more
|
|
ADVERTISEMENT
How to Build Productive, Strategic Sponsor-CRO Partnerships
Tuesday, April 27, 2021 at 1pm EDT | 12pm CDT | 10am PDT
Read more
|
|
|
|
|
|
Opterion Health (Sarnen, Sweden) appointed Björn Englund as CEO. He succeeds Guido Grentzmann.
|
|
|
Augustine Therapeutics (Leuven, Belgium) announced the appointment of Dr. Sylvain Celanire, Ph.D, as Chief Executive Officer and the opening of its drug discovery laboratories at the Leuven Bio-Incubator in Belgium.
|
|
|
Intravacc (Bilthoven, the Netherlands) appointed Nathalie Laarakker as Chief Financial Officer.
|
|
|
ENTEROME (Paris, France) named Anne Dagallier, Ph.D, as Chief Business Officer.
|
|
|
ERS Genomics, which provides broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, announced the appointment of Jon Kratochvil as Vice-President for Business Development & Licensing for North America.
|
|
|
EVONETIX (Cambridge, UK), a synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, announced the appointment of Michael Daniels, Ph.D, as Head of Product Management.
|
|
|
Global healthcare market research consultancy Research Partnership has appointed Roy Rogers as a Quantitative Director in their UK offices in London.
|
|
|
Global creative communications agency Page & Page and Partners (London, UK) appointed its new Senior Account Director, Charlotte Sale.
|
|
|
|
|
|
|
|
